The effects of p16INK4a-deficiency on inflammatory phenotype thus appear insufficient to affect atherosclerosis or the development of obesity and glucose intolerance suggesting the involvement of other cell types, other gene products or combinations thereof in the CDKN2A/B genomic region. This evidence concerns the gene CDKN2A and obesity due to melanocortin 4 receptor deficiency.